Join
Live feed
·
INSIDERFilingvia Quantisnow
Amicus Therapeutics Inc. logo

President and CEO Campbell Bradley L exercised 7,500 shares at a strike of $8.61 and sold $87,798 worth of shares (7,500 units at $11.71) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FOLD (Amicus Therapeutics Inc.) and more on Quantisnow.